指南与共识神经肿瘤

脑肿瘤手术中的输血指南:现有证据的系统综述与批判性总结

Transfusion Guidelines in Brain Tumor Surgery: A Systematic Review and Critical Summary of Currently Available Evidence.
指南 / 共识 · World Neurosurg · 2022-06-23

本系统综述检索PubMed、EMBASE和Google Scholar,依据PRISMA指南评估成人脑肿瘤手术患者红细胞输血阈值及围手术期输血相关并发症。共纳入7篇文章,发现输血与住院时间延长、重返手术室增加及30天死亡率升高相关;限制性血红蛋白阈值8 g/dL安全(C级IIa类)。

要点

  • 输血患者年龄更大、ASA 3或4级比例更高、合并症更多且手术时间更长。
  • 输血与住院时间延长、重返手术室增加及30天死亡率升高相关。
  • 限制性血红蛋白阈值8 g/dL安全(C级IIa类),可减少住院时间、死亡率和并发症。

核心结论

  • 限制性血红蛋白阈值8 g/dL在脑肿瘤手术患者中似乎安全,并能最小化输血的潜在并发症。

研究设计与样本

  • 系统综述,检索PubMed、EMBASE和Google Scholar数据库,依据PRISMA指南进行,共纳入7篇文章。

主要发现

  • 接受输血的患者年龄更大、美国麻醉医师协会(ASA)3或4级比例更高,合并糖尿病、高血压和心血管疾病等合并症更多,且手术时间延长。
  • 输血与多种术后重大和轻微并发症相关,包括住院时间延长、重返手术室增加和30天死亡率升高。
  • 限制性血红蛋白阈值8 g/dL安全,证据为住院时间、死亡率和并发症减少(C级IIa类)。

关键数值与推荐

  • 限制性血红蛋白阈值8 g/dL(C级IIa类)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Red blood cell (RBC) transfusion is commonly indicated in brain tumor surgery due to risk of blood loss. Current transfusion guidelines are based on evidence derived from critically ill patients and may not be optimal for brain tumor surgeries. Our study is the first to synthesize available evidence to suggest RBC transfusion thresholds in brain tumor patients undergoing surgery. METHODS: A systematic review was conducted using PubMed, EMBASE, and Google Scholar databases in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines to critically assess RBC transfusion thresholds in adult patients with brain tumors and complications secondary to transfusion following blood loss in the operating room or perioperative period. RESULTS: Seven articles meeting our search criteria were reviewed. Brain tumor patients who received blood transfusions were older, had greater rates of American Society of Anesthesiologists class 3 or 4, and presented with increased number of comorbidities including diabetes, hypertension, and cardiovascular diseases. In addition, transfused patients had a prolonged surgical time. Transfusions were associated with multiple postoperative major and minor complications, including longer hospital length of stay, increased return to the operating room, and elevated 30-day mortality. Analysis of transfusion thresholds showed that a restrictive hemoglobin threshold of 8 g/dL is safe in patients, as evidenced by a reduction in length of stay, mortality, and complications (level C class IIa). CONCLUSIONS: A restrictive Hb threshold of 8 g/dL appears to be safe and minimizes potential complications of transfusion in brain tumor patients.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Rail B, Hicks WH, Oduguwa E, et al. Transfusion Guidelines in Brain Tumor Surgery: A Systematic Review and Critical Summary of Currently Available Evidence. World Neurosurg. 2022. PMID: 35752421. doi:10.1016/j.wneu.2022.06.077

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。